Soleno Therapeutics, Inc. (SLNO) Stock Analysis
Free AI-powered analysis and research for Soleno Therapeutics, Inc. stock
Sector: Healthcare
Analyze Soleno Therapeutics, Inc. (SLNO) Stock
Soleno Therapeutics, Inc. (SLNO) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into SLNO stock performance, technical indicators, and AI-powered trading recommendations.
Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Soleno Therapeutics, Inc. stock.
Analyze SLNO Now βπ° Latest Update
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating
Tue, March 10, 2026 at 12:31 AM UTC 2 min read
H.C. Wainwright has lowered its price target on Soleno Therapeutics (SLNO) while maintaining a Buy rating. This adjustment reflects a reassessment of the company's growth prospects and market conditions, which could influence investor sentiment. Despite the reduced target, the Buy rating suggests that analysts still see potential for upside in SLNO shares, making it a stock to watch for investors seeking opportunities in the biotech sector.
π Technical Analysis
RSI, MACD, moving averages, support/resistance levels, and momentum indicators for Soleno Therapeutics, Inc. (SLNO) stock.
π€ AI Insights
AI-powered analysis of Soleno Therapeutics, Inc. (SLNO) fundamentals, growth prospects, and market position.
β οΈ Risk Assessment
Comprehensive risk analysis including volatility, sector risks, and market conditions for Soleno Therapeutics, Inc. stock.
Why Analyze Soleno Therapeutics, Inc. (SLNO) with StockIQ?
- β Free AI-powered analysis of Soleno Therapeutics, Inc. (SLNO) stock
- β Real-time technical indicators for Soleno Therapeutics, Inc. stock
- β Comprehensive risk assessment for SLNO
- β No credit card required